RE:Great job rvv! Hit 15.5 cents again. Revive Therapeutics Ltd. focuses on the development and commercialization of various drugs in Canada. The company develops REV-002, a bucillamine that has completed Phase II-A clinical studies for the treatment of acute gout flares. Its product pipeline also includes REV-004, a bucillamine for the treatment of cystinurial. The company has a research and development supply and collaboration agreement with WeedMD Inc. Revive Therapeutics Ltd. was incorporated in 2012 and is headquartered in Vaughan, Canada. Receive RVV News and Ratings via EmailSign-up to receive the latest news and ratings for RVV and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock ExchangeCVE IndustryBiotechnology Sub-IndustryN/A SectorMedical SymbolCVE:RVV CUSIPN/A Webwww.revivethera.com Phone+1-905-6055535 Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / CashN/A Book ValueN/A Price / BookN/A Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on Equity-125.95% Return on Assets-101.77% Miscellaneous EmployeesN/A Outstanding Shares57,520,000 Market CapC$13.52 million Revive Therapeutics (CVE:RVV) Frequently Asked QuestionsWhat is Revive Therapeutics' stock symbol? Revive Therapeutics trades on the Canadian Venture Exchange (CVE) under the ticker symbol "RVV." How were Revive Therapeutics' earnings last quarter? Revive Therapeutics Ltd (CVE:RVV) issued its earnings results on Wednesday, May, 30th. The company reported ($0.01) earnings per share (EPS) for the quarter.View Revive Therapeutics' Earnings History. When is Revive Therapeutics' next earnings date? Revive Therapeutics is scheduled to release their next quarterly earnings announcement on Thursday, October, 18th 2018.View Earnings Estimates for Revive Therapeutics. What is the consensus analysts' recommendation for Revive Therapeutics? 0 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Revive Therapeutics in the last year. There are currently for the stock, resulting in a consensus recommendation of "N/A." Who are some of Revive Therapeutics' key competitors? Some companies that are related to Revive Therapeutics includeBELLUS Health (BLU),Medicenna Therapeutics (MDNA),Destiny Pharma (DEST),NovaBay Pharmaceuticals (NBY),Rexahn Pharmaceuticals (RNN),Abzena (ABZA),OptiBiotix Health (OPTI),Scancell (SCLP),Synthetic Biologics (SYN),DiaMedica Therapeutics (DMA),Antibe Therapeutics (ATE),Biopharmx (BPMX),Realm Therapeutics (RLM),Ceapro (CZO)andNuvo Pharmaceuticals (NRI). Who are Revive Therapeutics' key executives? Revive Therapeutics' management team includes the folowing people:Mr. Craig Leon MBA,Chairman & CEO(Age 50)Mr. Fabio Chianelli,Pres & Director(Age 40)Mr. Carmelo Marrelli C.A.,C.P.A., CPA, B.Comm., CA, CGA, ACIS, Chief Financial Officer and Corp. Sec.(Age 47)Dr. Beverly J. Incledon,Vice-Pres of R&D(Age 50)Dr. Ram Subramanian M.D.,Scientific Advisor for Cannabinoid-Based Therapeutics Targeting Liver Diseases Has Revive Therapeutics been receiving favorable news coverage? Headlines about RVV stock have been trending somewhat positive recently, according to Accern Sentiment. The research firm identifies positive and negative press coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Revive Therapeutics earned a daily sentiment score of 0.16 on Accern's scale. They also gave headlines about the company an impact score of 47.42 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the next several days. How do I buy shares of Revive Therapeutics? Shares of RVV and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab. What is Revive Therapeutics' stock price today? One share of RVV stock can currently be purchased for approximately C$0.16. How big of a company is Revive Therapeutics? Revive Therapeutics has a market capitalization of C$13.52 million. How can I contact Revive Therapeutics? Revive Therapeutics' mailing address is 5 Director Crt Suite 105, WOODBRIDGE, ON L4L 4S5, Canada. The company can be reached via phone at +1-905-6055535. MarketBeat Community Rating for Revive Therapeutics (CVE RVV) Community Ranking:2.4 out of 5 ()Outperform Votes:37 (Vote Outperform)Underperform Votes:39 (Vote Underperform)Total Votes:76 MarketBeat's community ratings are surveys of what our community members think about Revive Therapeutics and other stocks. Vote "Outperform" if you believe RVV will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RVV will underperform the S&P 500 over the long term. You may vote once every thirty days.